Inhibition of Phosphodiesterase 2 Augments cGMP and cAMP Signaling to Ameliorate Pulmonary Hypertension
Kristen J. Bubb(The University of Sydney), Adrian J. Hobbs(Queen Mary University of London), Sarah L. Trinder(Queen Mary University of London), Reshma S. Baliga(Queen Mary University of London), Lucie H. Clapp(The London College), Jigisha Patel(University College London), Raymond J. MacAllister(Queen Mary University of London)
Cited by 88
Related Papers
Acute Blood Pressure Lowering, Vasoprotective, and Antiplatelet Properties of Dietary Nitrate via Bioconversion to Nitrite
|Hypertension|2008|1.1k
Transient Limb Ischemia Induces Remote Ischemic Preconditioning In Vivo
|Circulation|2002|712
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Terlipressin for norepinephrine-resistant septic shock
|The Lancet|2002|259